AGL Antikörper (N-Term)

Produktnummer ABIN6243594

Produktdetails anti-AGL Antikörper

Target: AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AGL Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF)

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This AGL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human AGL.

Klon: RB5106

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: IF: 1:10~50. WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Details zu AGL

Target: AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))

Andere Bezeichnung: AGL (AGL Produkte)

Synonyme: DDBDRAFT_0219237 antikoerper, DDBDRAFT_0234114 antikoerper, DDB_0219237 antikoerper, DDB_0234114 antikoerper, GDE antikoerper, 1110061O17Rik antikoerper, 9430004C13Rik antikoerper, 9630046L06Rik antikoerper, AI850929 antikoerper, C77197 antikoerper, amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase antikoerper, glycogen debranching enzyme antikoerper, glycogen debranching protein antikoerper, amylo-1,6-glucosidase, 4-alpha-glucanotransferase antikoerper, AGL antikoerper, agl antikoerper, MMAH_RS03870 antikoerper, Agl antikoerper

Hintergrund: AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing.

Molekulargewicht: 174764

NCBI Accession: NP_000019, NP_000633, NP_000634, NP_000635, NP_000636, NP_000637

UniProt: P35573

Pathways: Cellular Glucan Metabolic Process